Cure Pharmaceutical Holding Corp. (IFIN)
NYSE
Real-time Data
01:30 PM
Day's Range
3.4552 wk Range
1.31Overview - IFIN - Cure Pharmaceutical Holding Corp.
Key Statistics
Valuation
P/E (Trailing)
‪36.94‬
Price / Book
‪0.46‬
Profitability
Return on Assets
‪3.76%‬
Return on Equity
‪4.31%‬
Ownership
Shares Outstanding
10.58M
Market Cap - IFIN - Cure Pharmaceutical Holding Corp.
Peers - IFIN - Cure Pharmaceutical Holding Corp.
Peer Comparison
Compared with companies in Software - Application listed on NYSE.
- IFINNYSECure Pharmaceutical Holding Corp.50.97MMarket Cap+49.86%52-week change36.94P/E (Trailing)—Profit Margin
- CRMNYSEsalesforce.com Inc171.31BMarket Cap-18.50%52-week change24.06P/E (Trailing)‪18.73%‬Profit Margin
- AMTNYSEAmerican Tower Corporation81.91BMarket Cap-20.09%52-week change24.15P/E (Trailing)‪31.08%‬Profit Margin
- CMGNYSEChipotle Mexican Grill, Inc.46.69BMarket Cap-15.85%52-week change34.17P/E (Trailing)‪11.42%‬Profit Margin
- AIGNYSEAmerican International Group Inc.39.80BMarket Cap-8.76%52-week change13.82P/E (Trailing)‪11.08%‬Profit Margin
- EXRNYSEExtra Space Storage Inc.32.40BMarket Cap+4.51%52-week change32.34P/E (Trailing)‪27.28%‬Profit Margin
- FICONYSEFair Isaac Corporation25.32BMarket Cap-21.42%52-week change34.00P/E (Trailing)‪34.05%‬Profit Margin
Profile Summary - IFIN - Cure Pharmaceutical Holding Corp.
About
Cure Pharmaceutical Holding Corp. is a biopharmaceutical company focused on the development and commercialization of innovative drug delivery systems. It aims to improve patient adherence and experience by providing new methods for drug delivery, such as oral thin films and transdermal systems. Cure Pharmaceutical's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
